Organization: Health Canada
Year: 2025
Month: January
Request Number: A-2024-001192
Request Summary: Adverse Drug Reaction (ADR) for Dexilant. Report number: E2B_07470391. ADRs for Entyvio. Report numbers: E2B_07461648, E2B_07452627, 001110995, E2B_07490527. ADRs for Lisdexamfetamine dimesylate. Report numbers: E2B_07494414, E2B_07458121, 001112478, 001112935. ADR for Ondissolve. Report number: 001111664.
Disposition: Disclosed in part
Number of pages: 1014